Balchem (BCPC) Osake Kurssi
Balchem Kurssi
Viimeisten 19 vuoden aikana Balchemn liikevaihto kasvoi 13,0 % vuodessa ja ylsi 1,04 Mrd. USD:een. Osakekohtainen tulos on kasvanut 13,2 % vuodessa viimeisten 19 vuoden aikana. Balchemn nettomarginaali 14,9 % on noussut verrattuna 12,0 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,55 %. Jakosuhde on noin 20 % tuloksesta. Osinko on kasvanut 15,7 % vuodessa viimeisten 19 vuoden aikana. Balchemn 12 kuukauden konsensustavoitehinta on 215,00 USD, noin yli kurssia 24,1 %. 9 analyytikosta 7 suosittaa ostoa — kokonaiskonsensus on Osta.
Balchem osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Balchem liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Balchem -osakkeesta
Balchem Corp is a leading company with a unique business model. The company specializes in the development, manufacturing, and marketing of specialty performance ingredients and products, catering to various industries. Balchem Corp focuses on providing innovative solutions that enhance the health and well-being of people, animals, and plants. With a diverse portfolio, the company offers nutritional, flavor, and fragrance ingredients, as well as animal health products and specialty film solutions. Balchem Corp consistently aims to deliver high-quality products and services that meet the evolving needs of its customers, reinforcing its position as a trusted industry leader.
Balchem Corp is primarily active in the industries of nutrition and health, animal nutrition, specialty products, and industrial products.
The main competitors of Balchem Corp in the market include companies such as Archer Daniels Midland Company, Innophos Holdings Inc., and Corbion N.V.
Balchem Corp is a leading company in the specialty chemicals industry. Founded in 1967, Balchem Corp has established a strong reputation for delivering innovative solutions across various sectors including human and animal nutrition, food and beverage, and pharmaceuticals. The company's rich history spans over five decades, marked by continuous growth and strategic acquisitions. Balchem Corp remains committed to providing high-quality products and services, leveraging its expertise in encapsulation, chelation, and controlled release technologies. With a customer-centric approach and a focus on sustainable solutions, Balchem Corp continues to drive forward in its mission to enhance health and well-being through its diverse portfolio of products and cutting-edge research.
Balchem Corp has achieved several significant milestones in its history. One of the key milestones is its acquisition of certain assets of Animal Nutrition & Health (ANH) business from a leading global food company, AkzoNobel, in 2012. This acquisition allowed Balchem to expand its portfolio and become a leading provider of encapsulated nutraceuticals for both human and animal health markets. Additionally, the company has consistently demonstrated strong financial performance over the years, with increasing revenues and earnings. Furthermore, Balchem has established itself as a trusted name in the industry, known for its high-quality products and innovative solutions.
Balchem Corp is primarily present in the United States.
Balchem Corp represents a commitment to innovation, sustainability, and to making a positive impact in the industries it serves. The company focuses on delivering high-quality, science-based solutions that provide unique value to its customers. Balchem Corp places a strong emphasis on corporate responsibility, striving to operate in a socially and environmentally responsible manner. With a dedicated team and a customer-centric approach, the company aims to consistently provide exceptional products and services that meet the evolving needs of its clients.
Analyytikot asettavat tällä hetkellä Balchem-osakkeelle keskimääräisen tavoitehinnan 215,00 USD (mediaani: 215,00 USD), mikä merkitsee +24,1 % viimeisimpään hintaan verrattuna. Konsensus perustuu 9 analyytikkoarvioon.
9 analyytikkoa arvioi tällä hetkellä Balchem-osaketta: 7 suosittaa ostoa, 2 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Balchem-yhtiöltä 1,13 Mrd. USD liikevaihtoa ja 5,45 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Balchem-osake noteerataan hintaan 154,44 EUR (173,23 USD).
Balchem-osake (BCPC) on listattuna 5 pörssissä, muun muassa: NASDAQ (BCPC), SIX (Zürich) (BL9B.SW), Frankfurt (BL9B.F), München (BL9B.MU), Düsseldorf (BL9B.DU).
Balchem Corp is a leading company in the fields of animal nutrition, human nutrition, and industrial chemicals. The innovative company offers a wide range of products and solutions tailored to the needs of its customers. Balchem's animal nutrition division provides solutions for animal feed enhancement, health, and well-being of livestock, pets, and aquaculture. Balchem's products help animal owners improve the health of their animals and increase growth and productivity. Balchem uses innovative technologies to offer its customers powerful and effective feed enhancement solutions that provide significant benefits for animal health and performance. Balchem's human nutrition division offers solutions tailored to the health and needs of the modern consumer. Balchem's products include functional ingredients, vitamins, minerals, and amino acids used in food, beverages, supplements, and pharmaceutical products. Balchem aims to improve human health and well-being by offering innovative products that help consumers maximize their health and happiness. Balchem's industrial chemicals division offers a variety of solutions for applications in agriculture, industry, and other industries. Balchem produces and distributes chemicals that can be used for many different purposes, including pesticides, defoliants, flame retardants, and many more. Balchem leverages its experience and expertise in the chemical industry to offer innovative solutions to its customers, helping them achieve their business goals. An example of a Balchem product is Choline Chloride, which is known as an essential nutrient for animals. It supports the growth and maintenance of cells and tissues, especially the nervous system. It is necessary for the synthesis of lecithin, which is an important component of any cell membrane. Overall, Balchem's business model is based on providing innovative, customer-oriented solutions tailored to the needs of its customers. The company has a strong focus on research and development of new products and technologies, which allows it to continuously enter new markets and remain competitive. By continuously evolving high-quality products and services, Balchem creates value for its customers and supports them in achieving their goals.
odotettu liikevaihto Balchem on 1,13 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Balchem on 176,17 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Balchem:n hinta-voitto-suhde (P/E) on tällä hetkellä 31,78. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Balchem-osakkeen arvostusta.
Balchem:n hinta-myynti-suhde (P/S) on tällä hetkellä 4,95. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Balchem-osakkeen arvostuskennuslukuna.
Balchem:n Eulpool-laatuscore on 6/10.
Balchem:n ISIN on US0576652004. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Balchem:n WKN on 905650. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Balchem:n ticker on BCPC. Tämä pörssinoteeraus käytetään Balchem-osakkeiden kauppaan pörssissä.
Balchem osake
Balchem vertaisryhmä
Balchem Ticker
Balchem FIGI
Kaikki tunnusluvut ja syvällinen analyysi Balchem:sta
Meidän osakeanalyysimme Balchem-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Balchem:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: